The estimated Net Worth of John P Wareham is at least $4.44 Milione dollars as of 1 November 2019. John Wareham owns over 20,492 units of Steris Plc stock worth over $4,443,253 and over the last 20 years John sold STE stock worth over $0.
John has made over 16 trades of the Steris Plc stock since 2010, according to the Form 4 filled with the SEC. Most recently John exercised 20,492 units of STE stock worth $1,193,454 on 1 November 2019.
The largest trade John's ever made was exercising 48,000 units of Steris Plc stock on 5 November 2010 worth over $792,000. On average, John trades about 10,361 units every 84 days since 2005. As of 1 November 2019 John still owns at least 18,356 units of Steris Plc stock.
You can see the complete history of John Wareham stock trades at the bottom of the page.
John's mailing address filed with the SEC is 761 MISSION CREEK DRIVE, , PALM SPRINGS, CA, 92211.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough e John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: